Credit Suisse Adjusts Estimates and PT on Stryker Following MAKO Acquisition

In a report published Monday, Credit Suisse analyst Bruce Nudell adjusted estimates and raised the price target on Stryker Corporation SYK from $77.00 to $84.00 following the MAKO Surgical Corp. MAKO acquisition. Credit Suisse added MAKO Surgical to Stryker estimates, raising 2013-2017 top-line CAGR by approximately 60bps to 5.5% CC. In the revised estimates, the analyst does not assume significant sales synergies which will likely prove conservative. Nudell lowered the 2014 EPS estimate from $4.69 to $4.53 due to the dilution of MAKO and unfavorable Fx. 2015 EPS estimated was also lowered from $5.14 to $5.11. Nudell forecasted 4Q13 sales of $2.41 billion versus consensus of $2.44 billion. Credit Suisse expects fourth quarter EPS or $1.23 versus consensus of $1.22. and implied guidance of $1.20-$1.26. The analyst concluded, "We like SYK's diversified business model & strong FCF generation. Moreover, we see MAKO as a good addition that could improve the ease & precision of complicated ortho procedures, which we believe could drive meaningful market share gains in SYK's hands longer term." Shares of Stryker closed at $78.15 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsBruce NudellCredit Suisse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!